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Abstract. The objective of this study was to characterize the baseline circadian rhythm of testosterone
levels in hypogonadal men. A total of 859 baseline proﬁles of testosterone from hypogonadal men were
included in this analysis. The circadian rhythm of the testosterone was described by a stretched cosine
function. Model parameters were estimated using NONMEM® 7.3. The effect of different covariates on
the testosterone levels was investigated. Model evaluation was performed using non-parametric
bootstrap and predictive checks. A stretched cosine function deeply improved the data goodness of ﬁt
compared to the standard trigonometric function (p<0.001; ΔOFV=−204). The effect of the age and the
semester, deﬁned as winter and spring versus summer and fall, were signiﬁcantly associated with the
baseline levels of testosterone (p<0.001, ΔOFV=−15.6, and p<0.001, ΔOFV=−47.0). Model evaluation
procedures such as diagnostic plots, visual predictive check, and non-parametric bootstrap evidenced that
the proposed stretched cosine function was able to model the time course of the diurnal testosterone
levels in hypogonadal males with accuracy and precision. The circadian rhythm of the testosterone levels
was better predicted by the proposed stretched cosine function than a standard cosine function.
Testosterone levels decreased by 5.74 ng/dL (2.4%) every 10 years and were 19.3 ng/dL (8.1%) higher
during winter and spring compared to summer and fall.
KEY WORDS: circadian rhythm; NONMEM®; stretched cosine function; testosterone.
INTRODUCTION
Testosterone affects almost every organ in the body (1).
Functions of testosterone include promoting spermatogenesis,
maintenance of accessory organs, muscle growth, development
of secondary sexual characteristics, erythropoiesis, bone metab-
olism, and feedback to the hypothalamus–pituitary (2,3). The
normal range for early morning total testosterone in healthy
adult males ranges from approximately 300 to 1000 ng/dL (4,5).
Low serum levels of total testosterone or hypogonadism (6)
have been associated with a number of morbidities including
cardiovascular disease, diabetes mellitus, low muscle mass, low
bone mass, low physical performance, and frailty (7).
Based on bioequivalence guidelines, the U.S. Food and
Drug Administration (FDA) recommends a cutoff value of
250 ng/dL in order to deﬁne hypogonadism for clinical trial
development and enrollment. In the present analysis, a mean
threshold of 300 ng/dL was used to consider a subject as
hypogonadal because it was the value used at screening in the
available studies, which was in agreement with the common
practice. Even though it has been widely discussed, the
threshold to consider a subject as hypogonadal is a
controversial issue, and different factors have to be consid-
ered in the diagnosis of hypogonadism (8). Since a diurnal
pattern where the highest level is reached early in the
morning is observed (9), hypogonadism diagnosis should be
performed within the time period of 8:00–10:00 a.m. (10).
Contrary to the substantial evidence for diurnal variation of
testosterone, reproducible data demonstrating seasonal pat-
terns of testosterone has been more elusive (11). While some
studies suggest its effects (12), others have failed to replicate
these results (13). Testosterone concentrations also change as
a function of age (14). In healthy men and starting at the third
decade of life, there is, on average, a decrease of 1–2% per
year (15). Moreover, the prevalence of hypogonadism has
recently increased (10). It has been reported that 12%, 19%,
28%, and 49% of men older than 50, 60, 70, or 80 years of
age, respectively, suffer from hypogonadism (14). That is the
reason why the use of testosterone replacement therapy
(TRT) has increased by more than 43% from 2010 to 2013
(16). Historically, the pathway to approval for a TRT required
pharmacokinetic but not clinical efﬁcacy criteria (17). Present
efﬁcacy endpoints included a requirement that more than
75% of the men treated with TRT reach testosterone levels
between the range of 300 and 1000 ng/dL.
The circadian pattern of testosterone has been extensively
investigated in healthy males. For example, Gupta et al. (18)
described the circadian rhythm of testosterone in healthy men;
however, they were not able to describe a circadian behavior in
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hypogonadal men,most likely due to the use of samples after the
administration of a transdermal system of testosterone. More-
over, in hypogonadal men, not only are the baseline values
lower, but the amplitude of variation is also smaller and thus
harder to characterize. Since testosterone is an endogenous
substance with a circadian behavior, the assessment of the
therapeutic effect of TRT results is challenging. To the best of
our knowledge, no model has characterized the time course of
the testosterone levels in hypogonadal men under Bbaseline^ or
pre-TRTconditions. It should be noted that the term Bbaseline^
is used in the current paper to refer to the absence of TRT. A
better understanding of the baseline testosterone kinetics in
hypogonadal men would be useful to compare the efﬁcacy
between different TRT because the magnitude of the difference
in the testosterone levels from the baseline could be considered
as the therapeutic TRT effect.
Consequently, the main objective of this analysis was to
build a population kinetic model to characterize the circadian
rhythm of the baseline testosterone levels in hypogonadal
men. This model would be used in the future to compare the
efﬁcacy of different TRT. The secondary objectives were to
quantify the sources of variability and to explore the impact
of patient characteristics on the testosterone kinetic param-
eters. In this paper, it will be demonstrated that a stretched
cosine function is more appropriate to describe the circadian
ﬂuctuations in the testosterone levels than a standard cosine
function. It will also be shown that the age of the patient and
more importantly the time of year have an impact in the
baseline levels of testosterone in hypogonadal men.
MATERIALS AND METHODS
Study Design and Patient Eligibility Criteria
A total of 859 baseline or pre-dose proﬁles of testoster-
one from seven internal studies conducted in hypogonadal
men were included in this analysis. Table I provides a
summary of the subject demographics by study and overall.
Usually, hypogonadism comes with a variety of other
complications. Nevertheless, the patients included in these
trials had no other medical condition. Subjects were included
in these studies if they had mean serum concentrations of
testosterone <300 ng/dL and an individual morning serum
concentration ≤350 ng/dL, they were 18 years old or older,
they had a body mass index (BMI) between 18 and 37 kg/m2,
and they provided their written informed consent The studies
took place in Québec (studies 2–6), Montréal (studies 1–3),
Toronto (study 1), North Carolina (studies 3 and 4), Florida
(study 4), San Antonio (study 2), and Germany (study 7).
Blood Sampling Schedule
Testosterone samples from studies 1 to 6 were analyzed
by inVentiv Health while testosterone samples in study 7 were
analyzed by Clinical Research Services Mannheim GmbH
Bioanalytical Laboratory. All the samples were analyzed
using a liquid chromatograph with a tandem mass spectrom-
etry detector (LC/MS/MS method). The calibration range of
the testosterone assay was 59.22–20,000 pg/mL. The accuracy
ranged between 91.10% and 99.99% with a precision ranging
between 1.68% and 66.07%. The lower limit of quantiﬁcation
was already provided in the calibration range (59.22 pg/mL).
Table II provides a summary of the study characteristics and
sampling schedules.
Pharmacokinetic Model Development
Software. Testosterone concentration–time proﬁles were
analyzed using the NONMEM® software (Icon Development
Solutions, Ellicott City, MD, USA), which included Version
7.3 installed on a Lenovo ThinkPad T430, equipped with
processor Intel i7 3520M, running under Windows 7® 32 bits.
Compilations were achieved using gfortran. Model
parameters were estimated using stochastic approximation
expectation maximization (SAEM) algorithm while standard
errors were computed using the Monte Carlo importance


















Age (years) 49.6 (22.0–67.0) 51.3 (22.0–71.0) 50.8 (27.0–72.0) 48.2 (31.0–76.0) 48.0 (21.0–71.0) 51.6 (30.0–72.0) 51.1 (32.0–68.0) 49.9 (21.0–76.0)
Body weight (kg) 86.7 (64.0–110) 87.9 (67.2–117) 86.3 (60.1–131) 86.8 (60.0–116) 88.8 (69.5–117) 82.9 (69.2–105) 90.6 (71.0–117) 87.0 (60.0–131)
Body mass index
(kg/m2)
28.3 (21.9–32.7) 28.7 (22.6–34.7) 28.7 (21.7–34.8) 28.7 (20.5–35.0) 29.0 (23.4–36.1) 27.8 (24.0–32.9) 28.8 (24.0–34.0) 28.6 (20.5–36.1)
Height (cm) 175 (162–187) 175 (164–194) 173 (164–194) 174 (162–188) 175 (163–186) 172 (162–184) 177 (165–188) 174 (162–194)
Ethnicity (N, %)
Hispanic/Latino 16 (11.0) 44 (24.9) 38 (29.0) 63 (44.1) 26 (18.6) 9 (10.6) 0 (0.0) 196 (22.8)
Non-Hispanic nor
Latino
130 (89.0) 133 (75.1) 93 (71.0) 80 (55.9) 114 (81.4) 76 (89.4) 40 (100) 663 (77.2)
Race (N, %)
White 124 (84.9) 161 (91.0) 115 (87.8) 119 (83.2) 140 (100) 82 (96.5) 37 (100) 778 (90.6)
Black 7 (4.8) 16 (9.0) 16 (12.2) 8 (5.6) 0 (0.0) 3 (3.5) 0 (0.0) 50 (5.8)
Asian 7 (4.8) 0 (0.0) 0 (0.0) 3 (2.1) 0 (0.0) 0 (0.0) 0 (0.0) 10 (1.2)
Others 8 (5.5) 0 (0.0) 0 (0.0) 13 (9.1) 0 (0.0) 0 (0.0) 0 (0.0) 21 (2.4)
Season (N, %)
Winter or spring 81 (55.5) 34 (19.2) 131 (100) 0 (0.0) 0 (0.0) 85 (100) 37 (100) 368 (42.8)
Summer or fall 65 (44.5) 143 (80.8) 0 (0.0) 143 (100) 140 (100) 0 (0.0) 0 (0.0) 491 (57.2)
Continuous variables are expressed as median (range), whereas categorical variables are expressed as counts, N and percentage (%)
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sampling (IMP) method. Graphical and all other statistical
analyses, including evaluation of NONMEM® outputs, were
performed using R version 3.1.0 running under the Rstudio
interface.
Structural Model. The circadian rhythm of testosterone
levels was described using a standard cosine function
according to Eq. 1:




where Amplitude represents the oscillation in the testosterone
levels, t represents the time, and Phase represents the time at
which the peak is achieved.
The complete time course of the testosterone levels was
characterized by the addition of a Base parameter to the
circadian function according to Eq. 2:
Testosterone tð Þ ¼ Circadian tð Þ þ Base ð2Þ
where Base represents the baseline levels of testosterone.
Statistical Model. Visual inspection of individual concen-
tration–time proﬁle suggested interindividual variability.
Between-subject or interindividual variability (IIV) in a
kinetic parameter, P, was included in the model, and it was
assumed to be log-normally distributed as shown in Eq. 3:
Pj ¼ P*e η jð Þ ð3Þ
where Pj is the individual kinetic parameter for the jth
individual, P* is the typical value of the kinetic parameter in
the population, and ηj is the parameter quantifying the
deviation of the individual parameter from the typical value.
ηj was assumed to have zero mean and variance ωP
2. The
magnitude of IIV was expressed as coefﬁcient of variation
(CV) calculated as the square root of ωP
2.
Residual variability was evaluated using a proportional
error model according to Eq. 4:
Tobs ¼ Tpred⋅ 1þ εð Þ ð4Þ
where Tobs is the observed testosterone level, Tpred is the
corresponding model prediction, and ε is a parameter
quantifying the residual variability, assumed to follow an
independent Gaussian distribution with mean zero and
variance σ2.
Model Selection Criteria. To identify the best statistical
model, a series of models were evaluated. For each model,
the improvement in the ﬁt obtained was assessed by the
likelihood ratio test (LRT) (p=0.001), the reduction in the
IIV and residual variability, the precision in parameter
estimates, the examination of diagnostic plots, and the
shrinkage (19).
Covariate Analysis. The effect of age, body weight, body
mass index (BMI), height, ethnicity, season, and semester was
explored as sources of IIV on the testosterone kinetic
parameters. In order to investigate a possible seasonal effect,
season was deﬁned as a covariate with four categories: winter,
spring, summer, and fall. Winter, spring, summer, and fall
were considered from December 21st to March 19th, from
March 20th to June 19th, from June 20th to September 21st,
and from September 22nd to December 20th, respectively.
Semester was split into two subcovariates. On the one hand,
semester 1 was deﬁned as a dichotomous variable with a
value of 0, if summer or fall, and a value of 1, if winter or
spring. On the other hand, semester 2 was deﬁned as a
dichotomous variable with a value of 0, if spring or summer,
and a value of 1, if fall or winter. Similarly, ethnicity was
deﬁned as a value of 0 for Hispanic or Latino and a value of 1
for non-Hispanic nor Latino. Race was not evaluated because
its categories were unbalanced. A screening analysis was
conducted only on the kinetic parameters where the shrink-
age was lower than 0.3 and was based on visual graphical

















0 ● ● ● ● ● ● ●
−2 ●
−4 ● ● ● ●
−6 ● ● ●
−8 ● ● ● ● ●
−10 ●
−12 ● ● ● ● ●
−14 ●
−16 ● ● ● ● ●
−18 ● ● ●




● Blood sample was collected at that time
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inspection and stepwise linear regression of the relationships
between the individual Bayesian kinetic parameters and the
covariates. Only covariates with statistically signiﬁcant
(p<0.05) and potentially clinically relevant (r2>0.2) effect on
kinetic parameters in the screening analysis were further
tested one by one in NONMEM® in order to be incorporated
in the population model.
The effect of selected covariates on model parameters
was explored following the forward-inclusion (p<0.005) and
backward-elimination (p<0.001) process as described else-
where (20). With this methodology, only covariates showing
signiﬁcant contributions were kept in the population model.
Categorical covariates were incorporated into the model as
index variables, whereas continuous covariates were included
using linear equations after centering on the median.
Model Evaluation. A visual predictive check was made
using the technique described by Yano et al. (21). The
parameter estimates obtained by ﬁtting the selected popula-
tion kinetic model to the data were used to simulate the
population kinetic proﬁle of the testosterone levels. Using
model predictions, a non-parametric 90% prediction interval
around the observed testosterone levels was constructed to
quantify the variability in the model predictions. Further-
more, normalized prediction distribution error (NPDE) was
also assessed (22). If the model adequately describes the data,
NPDE should follow a normal distribution with mean 0 and
variance 1. Finally, a non-parametric bootstrap was used as
internal evaluation method to qualify the estimates of the
model parameters (23). The mean and the 95% conﬁdence
intervals (CI) of the parameter estimates from the bootstrap
replicates were compared with the estimated parameters from
the original dataset.
RESULTS
The dataset analyzed in this study included seven
internal studies conducted at inVentiv Health. The model
ﬁtted a total of 859 baseline proﬁles of testosterone consisting
of 4556 observations. Table I summarizes the characteristics
of the patients included in this study. The internal model
evaluations were conducted under the same dataset. Model
parameters were estimated using SAEM algorithm followed
by IMP method in order to compute the standard error and to
obtain a value of the objective function to compare between
models.
A standard cosine function provided a reasonable
description of the time course of the baseline testosterone
levels. However, the plot of the testosterone levels versus
time (Fig. 1) revealed that after the morning peak, the
decrease in the testosterone levels is faster than the increase
from the nadir. This fact suggests an asymmetric circadian
rhythm of testosterone. Consequently, a stretched cosine
function was proposed. This function allows the time between
the peak of testosterone (tmax) and the nadir (tmin) to be
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Fig. 1. Time course of the baseline testosterone levels in hypogonadal men. Gray points represent observations. The blue line represents the
smooth regression line
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behavior. This equation has several components according to
Eqs. (5–7):
t24 ¼ t−tmaxð Þmod24 ð5Þ
where t24 is a vector of the difference between time t and tmax
modulo 24 h, that is, limited to a 24-h interval.
L1 ¼ tmin−tmaxð Þmod24 ð6Þ
where L1 is the length of the ﬁrst interval, in other words the
time that it takes from the peak of testosterone to the nadir
modulo 24 h as well.
L2 ¼ 24−L1 ð7Þ
L2 represents the length of the second interval, and thus,
the stretch of the cosine function (τ) can be deﬁned as shown
in Eq. 8:
τ
if t24≤ L1 then τ ¼ 12L1 t24
if t24 > L1 thenτ ¼ 12þ 12L2 t24−L1ð Þ
8><
>: ð8Þ
The new parameters to be estimated were tmax and tmin
instead of the phase shift, and as can be observed, τ depends
on tmax, tmin, and t. Therefore, the asymmetric circadian
rhythm can be deﬁned according to Eq. 9:




This parameterization had a major impact in the objective
function value (OFV), which decreases by 84 points compared
to the standard trigonometric function. Also, compared to a
double cosine function, the decrease was 40 points.
Moreover, the goodness of ﬁt was further improved by
the inclusion of IIV in tmax (ΔOFV=−49.9), tmin
(ΔOFV=−196), Amplitude (ΔOFV=−125), and Base
(ΔOFV=−3980). However, etabar problems in Base were


























































Fig. 2. a Distribution of the interindividual variability (eta) of Base by season before (left panel) and after (right panel) including the effect of
season in the model. Asterisks represent outliers. b Correlation between the interindividual variability (eta) of Base and age before (left
panel) and after (right panel) including the effect of age in the model. The blue solid line represents the smooth regression line
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distribution of the eta values in Base brought to light a certain
degree of skewness. Consequently, a Box–Cox transformation






where θ1 is a parameter to be estimated characterizing the
skewness of the distribution. Under this codiﬁcation, the
etabar problems disappeared and a signiﬁcant reduction in
the OFV was achieved (ΔOFV=−107). Moreover, at the
ﬁrst stage of the modeling, independence between the
interindividual random effects was assumed. However, the
graphical and statistical explorations of the correlations
among the IIV terms revealed a potential association
between tmax and tmin and between Amplitude and Base.
The correlations between these parameters were further
evaluated in NONMEM® by estimating the non-diagonal
elements of the variance–covariance matrix for the
between-subject random effects. The estimation of the off-
diagonal elements of the omega correlation matrix further
improved the model ﬁt to the data (ΔOFV=−150). For this
model, the shrinkage of the interindividual random effects
of tmax, tmin, Amplitude, and Base was 61%, 47%, 29%, and
4%, respectively.
The next step in the model building process was the
covariate analysis. Height was not tested because it was
included in the computation of the BMI. Out of 859 subjects
enrolled in this analysis, 778 (90.6%) were white or
Caucasian. Consequently, race was not evaluated because
its categories were not balanced. Scatterplots (for continu-
ous) or boxplots (for categorical) of the interindividual
random effects versus covariates were created in those
parameters where the shrinkage was lower than 0.3
(Amplitude and Base). This graphical analysis reveals a
slight trend between the baseline and the age (Fig. 2a) and
between the baseline and the semester (winter and spring vs
summer and fall) (Fig. 2b). The inclusion of the effect of age
and semester on Base improved the model ﬁt to the data
and decreased the OFV in a signiﬁcant extent
(ΔOFV=−15.6 and ΔOFV=−47.0, respectively). Age and
semester explained 2.5% and 3.4% of the variability in the
baseline values of testosterone. The search for sources of
IIV in those parameters where the shrinkage was higher
than 0.3 (tmax and tmin) was conducted with a formal analysis
in NONMEM® after exploring all the combinations. No
additional covariates other than the age and the season
were found to explain IIV in any parameter nor improved
the model ﬁt to the data. Consequently, the model described
was considered the best model to describe the time course




























20 30 40 50 60 70
Fig. 2. continued.
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Plots of observations versus population (Fig. 3a) and
individual (Fig. 3b) predicted concentration, and conditional
weighted residuals (CWRES) versus observations (Fig. 3c)
and versus time (Fig. 3d) showed random uniform scatter
around the identity line, indicating the absence of bias while
histograms of CWRES (Fig. 3e) and NPDE (Fig. 3f)
exhibited centered distribution around 0. The parameter
estimates and their associated precisions, measured as
relative standard error (RSE), for the best model are
presented in Table III. All structural model parameters, or
ﬁxed effects, were estimated with good precision
(RSE<33%), and random effects were estimated with very
good precision (RSE<17%).
The results of the visual predictive check performed are
presented in Fig. 4. In this plot, the blue lines represent the
percentiles 5th, 50th, and 95th based on the model predictions
and the shaded gray area between them represents the 90%
prediction interval (PI). For each of these percentiles, a 95%
PI was constructed (dotted blue lines around these percen-
tiles). The vertical dotted lines represent the selected bins.
For each bin, the percentiles 5th, 50th, and 95th based on the
observations were computed and plotted on top of model
prediction (horizontal blue solid lines), in order to visually
compare the variability in the model predictions. Besides, the
percentage of observations below the percentiles 5th, 50th,
and 95th was computed and plotted on the right margin of the
















































































































































Fig. 3. Diagnostic plots of the model developed to characterize testosterone kinetics in hypogonadal men. Left panels represent the scatterplots
of observations and population predictions (upper panel, a) and the observations and individual predictions (lower panel, b). Middle panels
show scatterplots of conditional weighted residuals and population predictions (upper panel, c) and time (lower panel, d). Right panels represent
the density plots of conditional weighted residuals (upper panel, e) and normalized prediction distribution errors (lower panel, f). Blue lines
represent the smooth regression line in scatterplots and the density line in density plots. Dotted black lines represent the theoretical density line
Table III. Non-parametric Bootstrap Analysis and Parameter Esti-











Base (ng/dL) 239 (1.1) 239 232, 245
Amplitude (ng/dL) 32.1 (3.5) 32.2 30.2, 34.1
tmax (clock time) 9:22 (0.4) 9:21 8:13, 10:30
tmin (clock time) 14:02 (0.4) 14:00 12:49, 15:33
Season on Base (%) 8.09 (18.8) 7.86 4.66, 11.0
Age on Base
(%/10 years)
−2.40 (24.0) −2.08 −0.07, −3.55
Box–Cox on Base −1.93 (2.4) −1.98 −1.69, −2.30
Interindividual variability (CV%)
ηBase 25.1 (3.6) 25.1 23.1, 27
ηAmplitude 50.3 (6.6) 50.2 43.5, 56.0
ηtmax 10.6 (19.1) 10.4 7.7, 14.4
ηtmin 19.0 (11.5) 19.4 16.0, 22.1
Residual variability (CV%)
σproportional 13.8 (2.4) 13.8 13.1, 14.4
Shrinkage values for tmax, tmin, Amplitude, Base parameters, and
residual variability were 60, 46, 27, 4, and 2%, respectively
Base baseline value, tmax time at which the peak of testosterone is
reached, tmin time at which the nadir of testosterone occurs
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plot. In this sense, 6.5%, 47.4%, and 95.1% of the observa-
tions were below the theoretical 5%, 50%, and 95%. This
ﬁgure evidences that the population kinetic model developed
was deeply appropriate to characterize the time course of the
baseline testosterone levels in hypogonadal men. Further-
more, the mean of NPDE was 0.019 (95% CI −0.011, 0.044)
and the value of the standard deviation was 0.986 (95% CI
0.964, 1.008).
Non-parametric bootstrap analysis was also used as an
internal model evaluation technique to qualify the devel-
oped model. From the 1000 bootstrap replicates, 0 (0%)
failed to minimize successfully. The analysis of the results
from the 1000 bootstrap replicates that minimized success-
fully is provided in Table III. The population estimates for
the ﬁnal model were very similar to the mean of the 1000
bootstrap replicates, and were contained within the 95%
conﬁdence intervals obtained from the bootstrap analysis.
Besides the accuracy, the precision of the NONMEM®
parameter estimates was also good, because the relative
standard error from the bootstrap analysis for the ﬁxed and
random effects were lower than 14% and 3%, respectively.
Overall, the validation results are satisfactory for this
dataset.
DISCUSSION
The primary goal of this analysis was to build a
population kinetic model in order to characterize the
circadian rhythm of the baseline testosterone levels in
hypogonadal men. A stretched cosine function was used to
describe the non-symmetric behavior in the circadian rhythm
of the testosterone levels. According to the estimated model
parameters, the time that it takes from the peak of
testosterone to the nadir was estimated to be around 5 h.
This means that after reaching the nadir, the increase until the
new peak is much slower (approximately 19 h). In this sense,
it was estimated that the peak of testosterone occurs around
9:20 in the morning, which is consistent with the clinical
practice for the diagnosis of hypogonadism (10). In this study,
a cutoff of 300 ng/dL was used to consider a subject with low
levels of testosterone. Accordingly, the base value of testos-
terone in hypogonadal men was estimated to be 239 ng/dL.
Moreover, the amplitude of the oscillation was estimated to
be 32.4 ng/dL, with an associated IIV higher than 50%.
Therefore, the modeled typical hypogonadal patient would


































Predicted 5%, 50% and 95% percentiles
95% CI of predicted percentiles
Observed testosterone levels
Observed 5%, 50% and 95% percentiles by bins
Fig. 4. Visual predictive check of the model developed to characterize the time course of the testosterone levels in hypogonadal men. Blue lines
represent the predicted 5th, 50th, and 95th percentiles of the testosterone concentrations. Dotted blue lines represent the 95% prediction
interval (PI) of these percentiles. The shaded gray area represents the 90% prediction interval (PI) predicted for the model. Vertical dotted lines
represent the selected bins. Gray solid lines represent the observed 5th, 50th, and 95th percentiles of testosterone concentrations in each bin.
Figures at the margin of the plot represent the theoretical (left) and observed (right) percentage of observations below percentiles 5th, 50th, and
95th
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During the model building process, a Box–Cox transfor-
mation was implemented because etabar problems in the
Base parameter were noticed. In population modeling, it is
commonly assumed that eta parameters follow a normal
distribution with a mean of 0 and a variance of ω2. However,
this is not always true as reported by Petterson et al. (24). The
authors’ suggested some transformation to relax the often
erroneous assumption of a known shape of the parameter
distribution. In our model, the additional parameter
estimated required for the Box–Cox transformation was
close to a value of −2, indicating negative skewness.
Within the range of values analyzed, body weight,
ethnicity, and smoke did not inﬂuence the circadian rhythm
of testosterone to a signiﬁcant extent. However, an increase
in age was associated with a decrement in the baseline values
of testosterone. Concretely, it was estimated that during a 10-
year span, the baseline concentration of testosterone would
be 5.74 ng/dL lower at the end of the period compared to the
beginning. These results are in concordance with the known
decrease in the testosterone levels with age (15). More
interesting was the fact that a seasonal effect was demon-
strated. Baseline testosterone levels were 8.09% higher
during the winter and spring compared to the summer and
fall. This difference might be clinically relevant because, on
average, a difference of 19.3 ng/dL is expected between
seasons. These results are in accordance with the ﬁndings of
Svartberg et al. (12). Effectively, in a study conducted in
Norway, these authors observed that free testosterone levels
showed a signiﬁcant seasonal pattern (P<0.001), with the
peak in December and the nadir in August. Lowest
testosterone levels occurred in months with the highest
temperatures and longest hours of daylight. In our study,
one explanation of the seasonal effect might be the variations
in temperature and daylight in the provinces of Québec and
Ontario, Canada, where the studies mainly took place. The
average temperatures in this area during winter and spring
are much lower than during the summer and fall, and also, on
average, the days are around 150 min shorter in terms of
sunlight. In this sense, it has been observed that lower
temperatures stimulate the pituitary gland to release lutein-
izing hormone (LH) and follicle-stimulating hormone (FSH)
during Bcold^ seasons (25). Besides, the peak of LH and FSH
occurs in March and February, respectively. It is also known
that physiologically, FSH and LH stimulate the testes to
synthesize testosterone and, consequently, the authors’ hy-
pothesis that the seasonal effect on the baseline values of
testosterone was due to an indirect effect because of the low
temperatures and the shorter hours of daylight. However, this
effect might not be observed in other parts of the world
where the temperature variations are not as important as in
the northern countries.
Model-based simulations of the time course of the
testosterone levels for young (27.9 years old) and old
(70.7 years old) subjects during winter and spring and
summer and fall are presented in Fig. 5. These simulations
are presented together with the time course of testosterone
levels in the typical young and old healthy subjects based on
the model developed by Gupta et al. (18). Both models
predict similar patterns with higher testosterone peaks early




























Gupta et al. [Healthy]
Stretched cosine [Hypogonadal]
Fig. 5. Simulation of the time course of the testosterone levels based on typical patient values. The horizontal black dashed line represents the
threshold for hypogonadism (300 ng/dL)
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evening. As expected, the simulations evidenced that lower
levels of testosterone would be easier observed in an old
subject compared to a young subject. Moreover, one subject
would be more likely diagnosed as hypogonadal during
summer and fall compared to winter and spring. Further-
more, it should be noted that the testosterone levels of a
young hypogonadal male during summer and fall will be
similar to the levels of an old hypogonadal male during
winter and spring. The simulations also evidence that a fast
decrease in the testosterone levels occurs after the testos-
terone peak. This fact might show the clinicians the optimal
time for the TRT to be administrated in order to maintain
the testosterone levels within the normal range of 300 and
1000 ng/dL.
Visual predictive check, normalized predictive distribu-
tion errors, and non-parametric bootstrap were used as
complementary tools to internally evaluate the model
developed. The bootstrap analyses conducted in the current
study yielded mean model parameters that were comparable
to the estimates of the original data set, indicating the
stability of the developed model. These ﬁndings were further
supported by the predictive checks performed, which con-
ﬁrmed the model developed was suitable to describe the time
course of testosterone levels in hypogonadal men. As a
result, the efﬁcacy between different TRT can be assessed by
the proposed model described above. Effectively, the time
course of the testosterone levels in hypogonadal men
depending on the age and the season of the year can be
simulated from our model. These proﬁles can be compared
with the proﬁles after the administration of TRT, and thus,
the therapeutic effect of different TRT would be easily
evaluated. Moreover, because of the use of a stretched cosine
function, it can be known that the lowest values of
testosterone after the peak occur faster than a 12-h interval.
Therefore, a more accurate dose regimen can be proposed to
minimize the impact of the circadian behavior of testoster-
one in hypogonadal men.
In summary, we demonstrated that a stretched cosine
function where the circadian rhythm was considered to be
asymmetric was the most suitable function to describe the
circadian behavior of the baseline testosterone levels in
hypogonadal men. The proposed stretched cosine function
might also be useful in all those situations where a non-
symmetric circadian rhythm is observed in order to improve
model predictions. Age and season were identiﬁed as
predictors of the baseline testosterone levels. The present
model manages to well characterize the population and
individual kinetics of the testosterone levels, making it
suitable to compare the efﬁcacy between different TRT.
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